Increasing recognition and emerging therapies argue for dedicated clinical trials in chronic myelomonocytic leukemia - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Leukemia Année : 2021

Increasing recognition and emerging therapies argue for dedicated clinical trials in chronic myelomonocytic leukemia

Fichier non déposé

Dates et versions

hal-04438578 , version 1 (05-02-2024)

Identifiants

Citer

Aline Renneville, Mrinal Patnaik, Onyee Chan, Eric Padron, Éric Solary. Increasing recognition and emerging therapies argue for dedicated clinical trials in chronic myelomonocytic leukemia. Leukemia, 2021, 35 (10), pp.2739-2751. ⟨10.1038/s41375-021-01330-1⟩. ⟨hal-04438578⟩
5 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More